Founded in 2006, Amplexa Genetics is one of the longest-established private genetic laboratories in the world. Our mission is to empower individuals and healthcare professionals with knowledge that supports clinically informed decision-making. In collaboration with leading scientific experts, Amplexa Genetics has developed over 100 clinical genetic tests, with primary applications in the fields of neurology and fertility. Our test portfolio focuses on genes with well-documented clinical relevance, where peer-reviewed scientific literature substantiates the disease-causing effects of genetic variants. Amplexa Genetics utilizes advanced instrumentation and state-of-the-art technologies, supported by proprietary in-house bioinformatics pipelines, to ensure accurate and reliable genetic analysis.
Looking for a particular Amplexa Genetics A/S employee's phone or email?
Amplexa Genetics A/S Questions
The Amplexa Genetics A/S annual revenue was $2 million in 2026.
Hans Dahl is the CEO of Amplexa Genetics A/S.
13 people are employed at Amplexa Genetics A/S.
Amplexa Genetics A/S is based in Odense C, Region Syddanmark.
The NAICS codes for Amplexa Genetics A/S are [11, 62, 621, 6215, 62151].
The SIC codes for Amplexa Genetics A/S are [7, 807, 75, 751, 80].
Top Amplexa Genetics A/S Employees
-
Hans Dahl
CEO at Amplexa Genetics A/S
Region of Southern Denmark, Denmark22 -
11
-
Sten Hindsgaul
Molekylær biolog at Amplexa Genetics A/S
Region of Southern Denmark, Denmark1
Related Companies
